{
    "title": "Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 bln deal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11091567/Pfizer-boost-pipeline-5-4-bln-Global-Blood-Therapeutics-buy.html",
    "date": "2022-08-08",
    "keywords": [
        "pfizer",
        "disease",
        "blood",
        "sickle",
        "cell",
        "revenue",
        "year",
        "company",
        "deal",
        "roy",
        "treatment",
        "gbt",
        "premium",
        "price",
        "decade",
        "infrastructure",
        "michael",
        "inc",
        "cash",
        "drugmaker",
        "surge",
        "covid19",
        "vaccine",
        "share",
        "closing",
        "bloomberg",
        "takeover",
        "interest",
        "street",
        "journal",
        "friday",
        "mark",
        "addition",
        "pill",
        "lookout",
        "end",
        "strategy",
        "diversification",
        "dealmaker",
        "interview",
        "growth",
        "half",
        "value",
        "cost",
        "malik",
        "size",
        "drug",
        "maker",
        "holding",
        "acquisition",
        "oxbryta",
        "pipeline",
        "peak",
        "disorder",
        "officer",
        "love",
        "uptake",
        "europe",
        "time",
        "money",
        "announcement",
        "monday",
        "reporting",
        "bengaluru",
        "editing",
        "ganguli",
        "david",
        "lincoln",
        "feast"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}